RedHill Biopharma Prices Public Offering of its American Depositary Shares
RedHill Biopharma Ltd. | November 08, 2017
RedHill Biopharma Ltd. (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer.